Sign up to save your podcasts
Or
Share The Lancet Respiratory Medicine: January 27, 2014
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lancet Respiratory Medicine: January 27, 2014
Victor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs.
View all episodes
By The Lancet Respiratory MedicineVictor Ortega discusses the effect of rare ADRB2 variants of risk on severe asthma exacerbations in patients receiving treatment with LABAs.